![Ashley Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashley Hall
Corporate Officer/Principal chez
STRUCTURE THERAPEUTICS INC.
Fortune : 2 M $ au 31/05/2026
Profil
Ms. Ashley F.
Hall is a Chief Development Officer at Structure Therapeutics, Inc. Ms. Hall was previously employed as a Chief Development Officer by Reneo Pharmaceuticals, Inc., a Senior VP-Global Regulatory Affairs & Policy by Esperion Therapeutics, Inc., a Vice President-Regulatory Affairs by Amgen Rockville, Inc., a Director-World Wide Regulatory Affairs by MedImmune LLC, a Vice President-Regulatory Affairs by CancerVax Corp., a Vice President-Regulatory Affairs by Micromet, Inc., and a Vice President-Regulatory & Clinical Affairs by Revogenex Ltd. She received her undergraduate degree from the University of California San Diego and a graduate degree from the University of San Diego School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/03/2026 | 155 187 ( 0,11 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Ashley Hall
| Sociétés | Poste | Début |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 18/09/2024 |
Anciens postes connus de Ashley Hall
| Sociétés | Poste | Fin |
|---|---|---|
| ONKURE THERAPEUTICS, INC. | Corporate Officer/Principal | 13/09/2024 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Conseiller Juridique Général | 01/05/2012 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Conseiller Juridique Général | 01/08/2009 |
Micromet Inc.
 Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Conseiller Juridique Général | - |
CancerVax Corp.
 CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Conseiller Juridique Général | - |
Formation de Ashley Hall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Revogenex Ltd.
 Revogenex Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of San Diego School of Law
 University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Pharmaceuticals, Inc.
 Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Micromet Inc.
Micromet Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases | Health Technology |
Choisissez Zonebourse 
